Review examines diagnosis, management of preschool wheeze

Review examines diagnosis, management of preschool wheeze

(HealthDay)—Preschool children have high asthma morbidity, and further research on the short- and long-term outcomes is needed, according to a review published online May 3 in The Lancet. This review is part of a series published ahead of World Asthma Day on May 6 and the annual meeting of the American Thoracic Society, held from May 16 to 21 in San Diego.

Francine M. Ducharme, M.D., from the Sainte-Justine University Health Centre in Montreal, and colleagues conducted a systematic review to investigate diagnosis, management, and prognosis of preschool wheeze.

The researchers note that have higher asthma morbidity than other age groups, and that preschool wheeze is highly prevalent. The diagnosis of wheeze in is challenging, with the two most frequent causes of wheezing being bronchiolitis and asthma. Different phenotypes have been identified, and the heterogeneity is due to interactions between genetics and pre- and postnatal environmental factors. Preschool children with wheeze have been suggested to have lasting deficits in lung function that persist into adulthood. In trials of children with interim symptoms or atopy, the most effective therapy for recurrent wheezing was daily-inhaled corticosteroids, while intermittent high-dose inhaled corticosteroids seemed effective for moderate-to-severe viral-induced wheezing without interim symptoms.

"Irrespective of phenotype, researchers need to document whether achieved rapidly after the initial diagnosis in early childhood predicts medium-term and long-term disease evolution (remission, persistence, and recurrence); acute-care use of health resources (morbidity); and consequently health care costs," the authors write.

One author disclosed financial ties to the pharmaceutical industry.

More information: Abstract
Full Text (subscription or payment may be required)
Editorial

add to favorites email to friend print save as pdf

Related Stories

Wheezing and asthma in young children

Oct 07, 2008

The diagnosis of asthma in a young child may well be more challenging to pediatricians than previously appreciated, according to a review of research and clinical experience literature by Howard Eigen, M.D., of the Indiana ...

Recommended for you

PCV13 recommended for 6- to 18-year-olds at high risk

14 hours ago

(HealthDay)—Pneumococcal conjugate vaccine 13 (PCV13) should be administered to certain children aged 6 through 18 years who are at high risk of invasive pneumococcal disease (IPD), according to a policy ...

Brain abnormality found in group of SIDS cases

Nov 25, 2014

More than 40 percent of infants in a group who died of sudden infant death syndrome (SIDS) were found to have an abnormality in a key part of the brain, researchers report. The abnormality affects the hippocampus, ...

Eczema cases rising among US children

Nov 24, 2014

(HealthDay)—A growing number of children are being diagnosed with the allergic skin condition eczema—but it can usually be eased with topical treatments, according to a new report.

Adult-sized ATVs deadly for kids, report shows

Nov 24, 2014

(HealthDay)—Santa might think twice about giving kids an all-terrain vehicle this year. Riding ATVs poses high risks of injury or death for children and teens, with dangers differing by age, a new U.S. ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.